Continuous glucose monitor study for seafarers with diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests if wearing a continuous glucose monitor (CGM) for 12 months helps seafarers on insulin better manage their blood sugar levels while at sea. You'll also use an app to log readings and activities.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a seafarer who needs insulin to control your diabetes.
- You have a valid ML5 or ENG1 medical certificate.
- You can wear a continuous glucose monitor (a small sensor on your skin) for 12 months.
- You are able to use a smartphone app to track your blood sugar readings and activities while at sea.
- You are of any ethnicity.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with diabetes feel about using a continuous glucose monitor (CGM) and their blood sugar readings. It aims to learn what works best for patients and healthcare providers to improve diabetes care.
This study tests a new continuous glucose monitor (CGM) that you wear for 14 days. It checks how accurate the device is and how well it helps track your blood sugar levels, all while being safe and easy to use.
This study tests whether using a continuous glucose monitor (CGM) helps people without diabetes improve their insulin sensitivity. You would wear a small sensor that tracks your glucose levels in real time, and the study may help you understand how your body responds to food and activity.
This study will look at how well Dexcom continuous glucose monitors (CGMs) work in real life. It helps people with diabetes track their blood sugar levels and may lead to better control of their condition.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
This trial tests a new continuous glucose monitor (a small sensor that checks blood sugar levels) to see how well and safely it works in people with type 1 diabetes. You'll wear the sensor for 15 days and attend three clinic visits to check its accuracy against blood samples.
Hear when a new Insulin Dependent Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.